We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIE
1976
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $1.18M | ﹤0.01% |
27,119
+20,897
| +336% | +$946K |
|
1977
World Acceptance Corp
WRLD
$873M
| $1.17M | ﹤0.01% |
17,884
-2,095
| -10% | -$131K |
|
|
DVAX
1978
DELISTED
Dynavax Technologies
DVAX
| $1.17M | ﹤0.01% |
131,933
+30,134
| +30% | +$152K |
|
1979
Insteel Industries
IIIN
$625M
| $1.17M | ﹤0.01% |
61,315
-6,080
| -9% | -$103K |
|
1980
Kearny Financial
KRNY
$599M
| $1.17M | ﹤0.01% |
142,679
+6,867
| +5% | +$57.5K |
|
1981
Nabors Industries
NBR
$1.21B
| $1.17M | ﹤0.01% |
31,524
+8,237
| +35% | +$237K |
|
1982
Kura Oncology
KURA
$850M
| $1.16M | ﹤0.01% |
71,359
+28,878
| +68% | +$417K |
|
1983
Repay Holdings
RPAY
$327M
| $1.16M | ﹤0.01% |
+47,162
| New | +$951K |
|
|
SWTX
1984
DELISTED
SpringWorks Therapeutics
SWTX
| $1.16M | ﹤0.01% |
27,644
+15,392
| +126% | +$548K |
|
|
HIBB
1985
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.16M | ﹤0.01% |
55,418
-9,040
| -14% | -$151K |
|
1986
Unitil
UTL
$980M
| $1.15M | ﹤0.01% |
25,724
+492
| +2% | +$24K |
|
1987
Assembly Biosciences
ASMB
$529M
| $1.15M | ﹤0.01% |
4,112
+417
| +11% | +$97.3K |
|
1988
Douglas Dynamics
PLOW
$1.02B
| $1.15M | ﹤0.01% |
32,728
+2,396
| +8% | +$83.1K |
|
1989
Par Pacific Holdings
PARR
$3.32B
| $1.14M | ﹤0.01% |
126,965
-3,697
| -3% | -$31.8K |
|
1990
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $1.14M | ﹤0.01% |
57,757
+8,614
| +18% | +$171K |
|
|
FSB
1991
DELISTED
Franklin Financial Network, Inc.
FSB
| $1.14M | ﹤0.01% |
44,270
-3,815
| -8% | -$89.3K |
|
|
ONEM
1992
DELISTED
1Life Healthcare
ONEM
| $1.13M | ﹤0.01% |
31,221
+7,032
| +29% | +$198K |
|
|
GOOD
1993
Gladstone Commercial Corp
GOOD
$627M
| $1.13M | ﹤0.01% |
60,394
+1,448
| +2% | +$23.7K |
|
1994
AdvanSix
ASIX
$444M
| $1.13M | ﹤0.01% |
96,065
-9,682
| -9% | -$113K |
|
1995
Inseego
INSG
$90.5M
| $1.13M | ﹤0.01% |
9,722
+2,966
| +44% | +$314K |
|
|
ZYXI
1996
DELISTED
Zynex
ZYXI
| $1.13M | ﹤0.01% |
49,843
+34,890
| +233% | +$584K |
|
1997
The RealReal
REAL
$1.5B
| $1.13M | ﹤0.01% |
88,051
+13,191
| +18% | +$157K |
|
1998
Caleres
CAL
$487M
| $1.12M | ﹤0.01% |
134,676
-15,810
| -11% | -$111K |
|
1999
EverQuote
EVER
$906M
| $1.12M | ﹤0.01% |
19,245
+9,955
| +107% | +$468K |
|
2000
Phreesia
PHR
$773M
| $1.12M | ﹤0.01% |
39,562
+7,714
| +24% | +$201K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.